Spectral Announces Appointment of Dr. Masayuki Kaneko to Its Board of Directors

TORONTO, ONTARIO--(Healthcare Sales & Marketing Network) - Spectral Medical Inc. ("Spectral" or the "Company") (EDT.TO) (EDTXF) a Phase III company developing the first treatment for patients with endotoxemic septic shock using a medica... Devices, Personnel Spectral Medical, Toraymyxin, septic shock

Source: HSMN NewsFeed - December 5, 2016 Category: Pharmaceuticals Source Type: news